Skip to main content

Immatics N.V.

IMTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001809196

In the last 90 days, Immatics N.V. insiders filed 1 open-market purchase and 0 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $1.01B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Immatics N.V. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
1 filing
1 insider, $7.50M in total
Open-market sells
0 filings
Insiders trading
1
Net value
+$7.50M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Immatics N.V., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Immatics N.V.
NameTitleLast reported holdingLast filingFilings, past year
Edelman JosephDirector11,246,516IndirectAug 27, 20261
Perceptive Advisors LLCDirector11,246,516IndirectAug 27, 20262
Perceptive Life Sciences Master Fund LtdDirector11,246,516IndirectAug 27, 20261
Pepin James NelsonGen Counsel and Corp Secretary–Aug 18, 20261
Atieh Michael GDirector–Jun 18, 20261
Mason Heather LDirector–Jun 18, 20261
Carter Paul RutherfordDirector–Jun 18, 20261
Stone Adam LeoDirector–Jun 18, 20261
Reicin AliseDirector–Jun 18, 20261
Forster EliotDirector–Jun 18, 20261
Hothum MathiasDirector–Jun 18, 20261
Chambre Peter AlanDirector–Jun 18, 20261

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 27, 2026 (view filing)4:00 PM ETAug 261 dayEdelman Joseph and 2 othersDirectorPPurchase+863.1K$8.69+$7.50M+8.3%11.2M after